Trial Details
TERMINATEDBasic Information
| Clinical ID | c1449 |
|---|---|
| Identifier | NCT05019742 |
| Trial Title | Evaluation of SPH3127 in Patients With Mild-to-Moderate Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: SPH3127|DRUG: Placebo |
Participant Information
| Sponsor | Shanghai Pharma Biotherapeutics USA Inc. |
|---|---|
| City | Huntsville |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2022-03-21 |
|---|---|
| Primary Completion Date | 2022-11-01 |
| Completion Date | 2022-11-01 |